BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17095208)

  • 1. The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingo-oophorectomy.
    Bresser PJ; Seynaeve C; Van Gool AR; Niermeijer MF; Duivenvoorden HJ; van Dooren S; van Geel AN; Menke-Pluijmers MB; Klijn JG; Tibben A
    Eur J Cancer; 2007 Jan; 43(1):95-103. PubMed ID: 17095208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical risk reduction: prophylactic salpingo-oophorectomy and prophylactic mastectomy.
    Dowdy SC; Stefanek M; Hartmann LC
    Am J Obstet Gynecol; 2004 Oct; 191(4):1113-23. PubMed ID: 15507929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Who is prone to high levels of distress after prophylactic mastectomy and/or salpingo-ovariectomy?
    Bresser PJ; Van Gool AR; Seynaeve C; Duivenvoorden HJ; Niermeijer MF; van Geel AN; Menke M; Klijn JG; Tibben A
    Ann Oncol; 2007 Oct; 18(10):1641-5. PubMed ID: 17660493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled study of mental distress and somatic complaints after risk-reducing salpingo-oophorectomy in women at risk for hereditary breast ovarian cancer.
    Michelsen TM; Dørum A; Dahl AA
    Gynecol Oncol; 2009 Apr; 113(1):128-33. PubMed ID: 19178933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
    Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
    Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of prophylactic salpingo-oophorectomy on quality of life and psychological distress in women with a BRCA mutation.
    Finch A; Metcalfe KA; Chiang J; Elit L; McLaughlin J; Springate C; Esplen MJ; Demsky R; Murphy J; Rosen B; Narod SA
    Psychooncology; 2013 Jan; 22(1):212-9. PubMed ID: 21913283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy.
    Lamb JD; Garcia RL; Goff BA; Paley PJ; Swisher EM
    Am J Obstet Gynecol; 2006 Jun; 194(6):1702-9. PubMed ID: 16731090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic oophorectomy in women at increased cancer risk.
    Domchek SM; Rebbeck TR
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):27-30. PubMed ID: 17218848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study.
    Brandberg Y; Sandelin K; Erikson S; Jurell G; Liljegren A; Lindblom A; Lindén A; von Wachenfeldt A; Wickman M; Arver B
    J Clin Oncol; 2008 Aug; 26(24):3943-9. PubMed ID: 18711183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of prophylactic bilateral salpingo-oophorectomy compared with gynecologic screening use in BRCA1/2 mutation carriers.
    Madalinska JB; van Beurden M; Bleiker EM; Valdimarsdottir HB; Lubsen-Brandsma L; Massuger LF; Mourits MJ; Gaarenstroom KN; van Dorst EB; van der Putten H; Boonstra H; Aaronson NK
    J Clin Oncol; 2007 Jan; 25(3):301-7. PubMed ID: 17235045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer.
    Madalinska JB; Hollenstein J; Bleiker E; van Beurden M; Valdimarsdottir HB; Massuger LF; Gaarenstroom KN; Mourits MJ; Verheijen RH; van Dorst EB; van der Putten H; van der Velden K; Boonstra H; Aaronson NK
    J Clin Oncol; 2005 Oct; 23(28):6890-8. PubMed ID: 16129845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short term psychological distress in patients actively approached for genetic counselling after diagnosis of breast cancer.
    Schlich-Bakker KJ; Wárlám-Rodenhuis CC; van Echtelt J; van den Bout J; Ausems MG; ten Kroode HF
    Eur J Cancer; 2006 Nov; 42(16):2722-8. PubMed ID: 16949277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aesthetic outcome, patient satisfaction, and health-related quality of life in women at high risk undergoing prophylactic mastectomy and immediate breast reconstruction.
    Isern AE; Tengrup I; Loman N; Olsson H; Ringberg A
    J Plast Reconstr Aesthet Surg; 2008 Oct; 61(10):1177-87. PubMed ID: 17938010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.
    Metcalfe KA; Lubinski J; Ghadirian P; Lynch H; Kim-Sing C; Friedman E; Foulkes WD; Domchek S; Ainsworth P; Isaacs C; Tung N; Gronwald J; Cummings S; Wagner T; Manoukian S; Møller P; Weitzel J; Sun P; Narod SA;
    J Clin Oncol; 2008 Mar; 26(7):1093-7. PubMed ID: 18195327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body image and psychological distress after prophylactic mastectomy and breast reconstruction in genetically predisposed women: a prospective long-term follow-up study.
    den Heijer M; Seynaeve C; Timman R; Duivenvoorden HJ; Vanheusden K; Tilanus-Linthorst M; Menke-Pluijmers MB; Tibben A
    Eur J Cancer; 2012 Jun; 48(9):1263-8. PubMed ID: 22105017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignancies following bilateral salpingo-oophorectomy (BSO).
    Gotlieb WH; Barchana M; Ben-Baruch G; Friedman E
    Eur J Surg Oncol; 2006 Dec; 32(10):1231-4. PubMed ID: 16626923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancer.
    Antill Y; Reynolds J; Young MA; Kirk J; Tucker K; Bogtstra T; Wong S; Dudding T; Di Iulio J; Phillips KA
    Eur J Cancer; 2006 Mar; 42(5):621-8. PubMed ID: 16434187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer.
    Meiser B; Butow P; Price M; Bennett B; Berry G; Tucker K;
    J Womens Health (Larchmt); 2003 Oct; 12(8):769-78. PubMed ID: 14588127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
    Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
    Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy.
    Metcalfe KA; Esplen MJ; Goel V; Narod SA
    Psychooncology; 2004 Jan; 13(1):14-25. PubMed ID: 14745742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.